Department of Gastroenterology, Cardiff & Vale University Health Board, Heath Park, Cardiff, UK.
Centre for Trials Research, Cardiff University, Cardiff, UK.
Scand J Gastroenterol. 2023 Jun;58(6):619-626. doi: 10.1080/00365521.2022.2158754. Epub 2022 Dec 23.
Population-based studies of inflammatory bowel disease (IBD) in Cardiff have recorded data back to 1930 for Crohn's disease (CD) and 1968 for ulcerative colitis (UC). This study compares incidence and phenotype for 2005-2016 with past data.
All new IBD cases resident in the Cardiff at diagnosis were collected retrospectively for the 12-year period 2005-2016, and compared with previous Cardiff data for trends in incidence and phenotype. Overall incidence was age/sex corrected to the UK population.
There were 991 new patients: 34% had CD, 5.4% IBD unclassified (IBD-U) and 60.5% had UC. The corrected incidence of CD was 7.7 per 100,000 person years [95% CI 6.9-8.6]. CD incidence is significantly higher than previous Cardiff studies, but the annual percentage change (APC) for 1980-2016 of 0.06; [95%CI -0.02 to 0.14] is not significant, with a previous higher APC for 1953-1980 of 0.18, [95%CI 0.13 to 0.23]. Uncorrected IBD-U incidence was 1.3 per 100,000 person years [95% CI 1.0-1.7]. UC corrected incidence was 14.4 per 100,000 person years [95% CI 13.3-15.6]. Incidence of UC is greater than in previous studies but did not increase during the current 12-year period. CD distribution at diagnosis continues to change as in previous Cardiff studies, with further increase in colonic disease and ileocolonic, (42% L2, 28% L3) and reduction in isolated terminal ileal disease (29% L1).
Incidence of both CD and UC are no longer rising significantly, but the location of CD at diagnosis continues to change with an increase in colonic location.Key messagesWhat is already known? It is unclear whether the incidence of IBD has now plateaued in urbanised nations. Changes in Crohn's disease location are often not reported in incidence studies and terminal ileal disease has usually been reported as the commonest site of diseaseWhat is new here? The incidence of UC and Crohn's is no longer rising in Cardiff UK, but the phenotype has changed progressively over time with a continuing increase in colonic disease location and decrease in isolated terminal ileal diseaseHow can this study help patient care? Understanding that Crohn's colitis is the predominant location has implications for diagnostic tests and implications for treatment optionsIMPACT STATEMENTThis work shows that although IBD incidence is no longer rising, the pattern of Crohn's disease is changing with more colonic disease and less isolated terminal ileal disease.PRACTITIONER RELEVANCE STATEMENTThe changing pattern of Crohn's disease location has implications for diagnostic assessment and treatment of this disease.
加的夫基于人群的炎症性肠病(IBD)研究记录了自 1930 年以来的克罗恩病(CD)和 1968 年以来的溃疡性结肠炎(UC)的数据。本研究比较了 2005-2016 年与既往数据的发病率和表型。
回顾性收集了 2005-2016 年期间居住在加的夫的所有新的 IBD 病例,与既往加的夫数据比较发病率和表型的变化趋势。总体发病率经年龄/性别校正至英国人口。
共 991 例新患者:34%为 CD,5.4%为 IBD 未分类(IBD-U),60.5%为 UC。校正后的 CD 发病率为 7.7/100000 人年[95%CI 6.9-8.6]。CD 的发病率明显高于既往加的夫研究,但 1980-2016 年的年百分比变化(APC)为 0.06[95%CI -0.02 至 0.14]并不显著,而 1953-1980 年的 APC 较高,为 0.18[95%CI 0.13 至 0.23]。未经校正的 IBD-U 发病率为 1.3/100000 人年[95%CI 1.0-1.7]。UC 校正后的发病率为 14.4/100000 人年[95%CI 13.3-15.6]。UC 的发病率高于既往研究,但在当前 12 年期间并未增加。CD 的发病部位与既往加的夫研究一样仍在不断变化,结肠疾病和回结肠疾病进一步增加(42%为 L2,28%为 L3),孤立的末端回肠炎减少(29%为 L1)。
CD 和 UC 的发病率不再显著上升,但 CD 的发病部位仍在不断变化,结肠部位的疾病不断增加。
关键信息
已知的内容是什么?尚不清楚城市化国家的 IBD 发病率是否已经达到平台期。在发病率研究中,克罗恩病的位置变化通常没有报道,而末端回肠炎通常被报道为最常见的疾病部位
新的内容是什么?英国加的夫的 UC 和 CD 的发病率不再上升,但随着时间的推移,表型逐渐发生变化,结肠疾病的位置不断增加,孤立的末端回肠炎不断减少
这项研究如何帮助患者护理?了解到克罗恩病结肠炎是主要的发病部位,这对诊断检测和治疗方案都有影响。
影响说明
本研究表明,尽管 IBD 的发病率不再上升,但克罗恩病的发病模式正在发生变化,结肠疾病的比例增加,孤立的末端回肠炎减少。
实践意义
克罗恩病发病部位的变化对疾病的诊断评估和治疗有影响。